ImportRefusal LogoImportRefusal

COASPHARMA S.A.S.

⚠️ High Risk

FEI: 3012391062 • Bogota, Cundinamarca • COLOMBIA

FEI

FEI Number

3012391062

📍

Location

Bogota, Cundinamarca

🇨🇴

Country

COLOMBIA
🏢

Address

Calle 18 28a 43, , Bogota, Cundinamarca, Colombia

High Risk

FDA Import Risk Assessment

51.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

10
Total Refusals
1
Unique Violations
1/15/2020
Latest Refusal
8/22/2017
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
38.6×30%
Recency
0.0×20%
Frequency
41.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7510×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
1/15/2020
60SCY28RANITIDINE (ANTACID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
62LCY09TINIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
64LCY33FLUPREDNISOLONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
66MCY83HYDROXYZINE HCL (TRANQUILIZER)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
60SCF23METOCLOPRAMIDE (ANTACID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
60ZCY02ALBENDAZOLE (ANTIPARASITIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/15/2020
60SCY99ANTACID, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/17/2018
62LCB40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/22/2017
64BCA25HYDROCHLOROTHIAZIDE (DIURETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/22/2017
62OCA28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is COASPHARMA S.A.S.'s FDA import refusal history?

COASPHARMA S.A.S. (FEI: 3012391062) has 10 FDA import refusal record(s) in our database, spanning from 8/22/2017 to 1/15/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. COASPHARMA S.A.S.'s FEI number is 3012391062.

What types of violations has COASPHARMA S.A.S. received?

COASPHARMA S.A.S. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about COASPHARMA S.A.S. come from?

All FDA import refusal data for COASPHARMA S.A.S. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.